Cell Biotech Co. Ltd (049960) — Financial Flexibility Index
Cell Biotech Co. Ltd (049960) has a Financial Flexibility Index of 0.86x as of September 2025. Free cash flow of ₩6.44 Billion (operating CF ₩4.15 Billion minus capex ₩2.29 Billion) represents 1% of total liabilities (₩7.46 Billion). Check strategic asset allocation of Cell Biotech Co. Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cell Biotech Co. Ltd Financial Flexibility Index (2011–2024)
Historical Financial Flexibility Index trend for Cell Biotech Co. Ltd across 14 annual periods. See 049960 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Cell Biotech Co. Ltd (2011–2024)
Year-by-year free cash flow to debt coverage for Cell Biotech Co. Ltd. For the full company profile including market capitalisation, see market cap of Cell Biotech Co. Ltd.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.30x | ₩20.55 Billion | ₩19.27 Billion | ₩6.23 Billion | ▲ +99.8% |
| 2023 | 1.65x | ₩9.50 Billion | ₩7.82 Billion | ₩5.76 Billion | ▼ -17.4% |
| 2022 | 2.00x | ₩15.49 Billion | ₩12.81 Billion | ₩7.75 Billion | ▼ -21.4% |
| 2021 | 2.54x | ₩15.74 Billion | ₩14.89 Billion | ₩6.19 Billion | ▲ +6.9% |
| 2020 | 2.38x | ₩12.64 Billion | ₩9.56 Billion | ₩5.32 Billion | ▼ -43.2% |
| 2019 | 4.19x | ₩19.70 Billion | ₩10.23 Billion | ₩4.70 Billion | ▲ +27.6% |
| 2018 | 3.28x | ₩21.09 Billion | ₩13.98 Billion | ₩6.42 Billion | ▼ -26.1% |
| 2017 | 4.44x | ₩27.88 Billion | ₩22.53 Billion | ₩6.28 Billion | ▲ +40.5% |
| 2016 | 3.16x | ₩20.15 Billion | ₩17.99 Billion | ₩6.38 Billion | ▼ -9.2% |
| 2015 | 3.48x | ₩21.62 Billion | ₩18.24 Billion | ₩6.21 Billion | ▲ +61.6% |
| 2014 | 2.15x | ₩11.29 Billion | ₩9.91 Billion | ₩5.24 Billion | ▼ -48.7% |
| 2013 | 4.20x | ₩15.30 Billion | ₩8.99 Billion | ₩3.65 Billion | ▲ +70.9% |
| 2012 | 2.45x | ₩9.53 Billion | ₩6.17 Billion | ₩3.88 Billion | ▲ +102.5% |
| 2011 | 1.21x | ₩6.04 Billion | ₩5.45 Billion | ₩4.98 Billion | — |